Biotechnology Value Fund Ii Lp
See Remarks And Footnotes at Kymera Therapeutics, Inc. (KYMR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $174M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 26SEC | KYMRKymera Therapeutics, Inc. | Sell | 837,9141,960,881 held (−30%) | $106.50 | $89.2M | +5.5% |
| Jun 26SEC | KYMRKymera Therapeutics, Inc. | Sell | 627,5971,592,261 held (−28%) | $106.50 | $66.8M | +5.5% |
| Jun 26SEC | KYMRKymera Therapeutics, Inc. | Sell | 113,289240,123 held (−32%) | $106.50 | $12.1M | +5.5% |
| Jun 26SEC | KYMRKymera Therapeutics, Inc. | Sell | 51,85878,787 held (−40%) | $106.50 | $5.5M | +5.5% |
- Sell
See Remarks And Footnotes Biotechnology Value Fund Ii Lp sold $89.2M of KYMR at $106.50 — cuts the stake by 30%.
- Sell
See Remarks And Footnotes Biotechnology Value Fund Ii Lp sold $66.8M of KYMR at $106.50 — cuts the stake by 28%.
- Sell
See Remarks And Footnotes Biotechnology Value Fund Ii Lp sold $12.1M of KYMR at $106.50 — cuts the stake by 32%.
- Sell
See Remarks And Footnotes Biotechnology Value Fund Ii Lp sold $5.5M of KYMR at $106.50 — cuts the stake by 40%.